Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2025-12-31 @ 3:21 AM
Study NCT ID:
NCT00910533
Status:
UNKNOWN
Last Update Posted:
2018-10-16
First Post:
2009-05-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study on Early Lyme Neuroborreliosis
Sponsor:
University Medical Centre Ljubljana
Organization:
Study Overview
Official Title:
Clinical and Microbiological Parameters in Patients With Early Lyme Neuroborreliosis
Status:
UNKNOWN
Status Verified Date:
2017-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine clinical course and the sequelae of early Lyme neuroborreliosis after treatment with ceftriaxone.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: